Prestige Consumer Healthc... (PBH)
Prestige Consumer Healthcare Inc. (PBH) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 2.4B |
| Revenue (ttm) | 1.1B |
| Net Income (ttm) | 172.01M |
| Beta | 0.33 |
| EPS (ttm) | 3.57 |
| PE Ratio (ttm) | 14.17 |
| Forward PE | 9.95 |
| P/B (ttm) | 1.25 |
| P/S (ttm) | 2.17 |
| Earnings Date | Nov 5, 2026 |
| Ask | n/a |
| Volume | 341,158 |
| Avg. Volume (20D) | 633,398 |
| Open | 51.00 |
| Previous Close | 50.04 |
| Day's Range | 50.51 - 51.27 |
| 52-Week Range | 42.62 - 71.07 |
| Analyst | Buy |
| Price Target | 70 (38.42%) |
| Dividends | n/a |
| Ex-Dividend Date | Dec 27, 2013 |
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for ba...
Financial Performance
In 2026, Prestige Consumer Healthcare's revenue was 1.09B, a decrease of -4.31% compared to the previous year's 1.14B. Earnings were 190.3M, a decrease of -11.32%.
Financial StatementsAnalyst Forecast
According to 5 analyst ratings, the average rating for PBH stock is "Buy". The 12-month stock price forecast is 70, which is upside of 38.42% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
